From the Cover: COVID-19 lockdown induces disease-mitigating structural changes in mobility networks

In the wake of the COVID-19 pandemic many countries implemented containment measures to reduce disease transmission. Studies using digital data sources show that the mobility of individuals was effectively reduced in multiple countries. However, it remains unclear whether these reductions caused deeper structural changes in mobility networks and how such changes may affect dynamic processes on the network. Here we use movement data of mobile phone users to show that mobility in Germany has not only been reduced considerably: Lockdown measures caused substantial and long-lasting structural changes in the mobility network. We find that long-distance travel was reduced disproportionately strongly. The trimming of long-range network connectivity leads to a more local, clustered network and a moderation of the “small-world” effect. We demonstrate that these structural changes have a considerable effect on epidemic spreading processes by “flattening” the epidemic curve and delaying the spread to geographically distant regions.

During the first phase of the coronavirus disease 2019 (COVID-19) pandemic, countries around the world implemented a host of containment policies aimed at mitigating the spread of the disease (1–4). Many policies restricted human mobility, intending to reduce close-proximity contacts, the major driver of the disease’s spread (5). In Germany, these policies included border closures, travel bans, and restrictions of public activity (school and business closures), paired with appeals by the government to avoid trips voluntarily whenever possible (6). We refer to these policies as “lockdown” measures for brevity.Based on various digital data sources such as mobile phone data or social media data, several studies show that mobility significantly changed during lockdowns (7). Most studies focused on general mobility trends and confirmed an overall reduction in mobility in various countries (8–12). Other research focused on the relation between mobility and disease transmission: For instance, it has been argued that mobility reduction is likely instrumental in reducing the effective reproduction number in many countries (13–17), in agreement with theoretical models and simulations, which have shown that containment can effectively slow down disease transmission (18–20).However, it remains an open question whether the mobility restrictions promoted deeper structural changes in mobility networks and how these changes impact epidemic spreading mediated by these networks. Recently, Galeazzi et al. (21) found increased geographical fragmentation of the mobility network. A thorough understanding of how structural mobility network changes impact epidemic spreading is needed to correctly assess the consequences of mobility restrictions not only for the current COVID-19 pandemic, but also for similar scenarios in the future.Here, we analyze structural changes in mobility patterns in Germany during the COVID-19 pandemic. We analyze movements recorded from mobile phones of 43.6 million individuals in Germany. Beyond a general reduction in mobility, we find considerable structural changes in the mobility network. Due to the reduction of long-distance travel, the network becomes more local and lattice-like. Most importantly, we find a changed scaling relation between path lengths and geographic distance: During lockdown, the effective distance (and arrival time in spreading processes) to a destination continually grows with geographic distance. This shows a marked reduction of the “small-world” characteristic, where geographic distance is usually of lesser importance in determining path lengths (22, 23). Using simulations of a commuter-based susceptible-infected-removed (SIR) model, we demonstrate that these changes have considerable practical implications as they suppress (or “flatten”) the curve of an epidemic remarkably and delay the disease’s arrival between distant regions.     

An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons.

Highly active antiretroviral therapy has decreased the morbidity and mortality of human immunodeficiency virus (HIV) infection, but latently infected cells remain for prolonged periods. CD4(+) CD45RO(+) T cells are a major latent virus reservoir in HIV-infected persons. Replication-competent, latently HIV-infected T cells can be generated in vitro by infecting peripheral blood mononuclear cells with HIV and then eliminating the HIV-producing cells with an anti-CD25 immunotoxin (IT). The CD25(-) latently infected cells then can be eliminated with an anti-CD45RO IT. This study determined whether this IT also could kill latently infected CD4 T cells from HIV-infected persons with or without detectable plasma viremia. The results show that ex vivo treatment of cells from HIV-positive persons by anti-CD45RO IT reduces the frequency of both productively and latently infected cells. In contrast, CD4(+) CD45RA(+) naive T cells and a proportion of CD4(+) CD45RO(lo) memory T cells are spared.     

Plasmodium vivax Pre-Erythrocytic-Stage Antigen Discovery: Exploiting Naturally Acquired Humoral Responses

Abstract. The development of pre-erythrocytic Plasmodium vivax vaccines is hindered by the lack of in vitro culture systems or experimental rodent models. To help bypass these roadblocks, we exploited the fact that naturally exposed Fy- individuals who lack the Duffy blood antigen (Fy) receptor are less likely to develop blood-stage infections; therefore, they preferentially develop immune responses to pre-erythrocytic-stage parasites, whereas Fy+ individuals experience both liver- and blood-stage infections and develop immune responses to both pre-erythrocytic and erythrocytic parasites. We screened 60 endemic sera from P. vivax-exposed Fy+ or Fy- donors against a protein microarray containing 91 P. vivax proteins with P. falciparum orthologs that were up-regulated in sporozoites. Antibodies against 10 P. vivax antigens were identified in sera from P. vivax-exposed individuals but not unexposed controls. This technology has promising implications in the discovery of potential vaccine candidates against P. vivax malaria.     

Clinical diagnosis of hyposalivation in hospitalized patients

Objective

The aim of this study was to evaluate the effectiveness of clinical criteria for the diagnosis of hyposalivation in hospitalized patients.

Material and Methods

A clinical study was carried out on 145 subjects (48 males; 97 females; aged 20 to 90 years). Each subject was clinically examined, in the morning and in the afternoon, along 1 day. A focused anamnesis allowed identifying symptoms of hyposalivation, like xerostomia complaints (considered as a reference symptom), chewing difficulty, dysphagia and increased frequency of liquid intake. Afterwards, dryness of the mucosa of the cheecks and floor of the mouth, as well as salivary secretion during parotid gland stimulation were assessed during oral examination.

Results

Results obtained with Chi-square tests showed that 71 patients (48.9%) presented xerostomia complaints, with a significant correlation with all hyposalivation symptoms (p<0.05). Furthermore, xerostomia was also significantly correlated with all data obtained during oral examination in both periods of evaluation (p<0.05).

Conclusion

Clinical diagnosis of hyposalivation in hospitalized patients is feasible and can provide an immediate and appropriate therapy avoiding further problems and improving their quality of life.     

The broad autism phenotype predicts child functioning in autism spectrum disorders

Background

Broad autism phenotype (BAP) is a milder expression of the social and communication impairments seen in autism spectrum disorders (ASD). While prior studies characterized the BAP in unaffected family members of probands with ASD, the relationship between parental BAP traits and proband symptomatology remains poorly understood. This study utilizes the Broad Autism Phenotype Questionnaire (BAPQ) in parents and the Social Responsiveness Scale (SRS) in children to examine this connection. We hypothesized that in families affected by ASD, elevated maternal and paternal BAPQ scores would correlate with greater autism symptomatology in diagnosed children. In an extension of prior research, we also explored this relationship in families with typically developing children (TDC).

Methods

Two hundred and forty-five children with ASD, 129 TDC and all parents were recruited as part of a larger study investigating relationships between genes, brain and behavior. The Autism Diagnostic Interview-Revised (ADI-R), Autism Diagnostic Observation Schedule (ADOS) and expert clinical judgment confirmed ASD diagnoses in children. SRS was collected for all children. Parents completed a self-report BAPQ and an informant report BAPQ for their spouse; an average of self-report and informant report for each parent was used in all analyses.

Results

Mothers and fathers of children with ASD had significantly higher rates of BAP traits as compared to parents of TDC. Maternal and paternal BAPQ total scores were not correlated with child IQ in either group. In the ASD group, 10% of mothers and 21% of fathers scored above the established BAP threshold compared to 4% of TDC parents. Crude regression analyses showed that maternal and paternal BAPQ total scores accounted for significant variance in child SRS scores in both ASD (17.1%) and TDC (19.8%) families.

Conclusions

Our results suggest that broad autism symptomatology in parents is moderately associated with their child’s autism symptomatology. This result extended to TDC families, suggesting that the BAPQ and SRS capture subtle, subclinical social variation in both children and adults. These findings could help define multi-generational social impairments in future phenotypic and genetic studies.